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Abstract  
Some strains of mouse hepatitis virus (MHV) can induce chronic inflammatory 
demyelination in mice that mimics certain pathological features of multiple sclerosis 
(MS). We have examined neural cell tropism of demyelinating and non-
demyelinating strains of mouse hepatitis virus in order to determine whether 
central nervous system (CNS) cell tropism plays a role in demyelination. Previous 
studies demonstrated that recombinant MHV strains, isogenic other than for the 
spike gene differ in the extent of neurovirulence and the ability to induce 
demyelination. Here we demonstrate that these strains also differ in their ability to 
infect particular cell type(s) in the brain.  Furthermore, there is a correlation 
between the differential localization of viral antigen in spinal cord gray matter 
versus white matter during acute infection and the ability to induce demyelination 
later on.  Viral antigen from demyelinating strains is detected initially in both gray 
and white matter, with subsequent localization to white matter of the spinal cord, 
whereas viral antigen localization of non-demyelinating strains is mainly restricted 
to gray matter.  This suggests that the localization of viral antigen to white matter 
during the acute stage of infection is essential for induction of chronic 
demyelination. Overall, these observations suggest that isogenic demyelinating 
and non-demyelinating strains of MHV, differing in the spike protein expressed, 
infect neurons versus glial cells in different proportions and that differential tropism 
to a particular CNS cell type may play a significant role in mediating the onset and 
mechanisms of demyelination.  
Introduction 
Multiple sclerosis (MS) is a common disabling neurological disease, 
pathologically characterized by demyelination, loss of oligodendroglial cells, and 
axonal degeneration (25, 26). The mechanisms that culminate in the destruction 
of oligodendrocytes and loss of central nervous system (CNS) myelin are not well 
understood.  The process is believed to involve a T-cell mediated autoimmune 
phenomenon that may be triggered by one or more viral infections (1). Several 
experimental viral model systems have been instrumental in providing these 
insights (2).  One of the animal models is based on mouse hepatitis virus (MHV)-
induced demyelination in mice that mimics the pathology of MS (12, 19, 21, 39, 
42).  Infection with neurotropic MHV strains produces a bi-phasic neurological 
disease with acute meningoencephalitis preceding the onset of chronic 
demyelination (21). 
 
Following intracranial inoculation (i.c.), MHV is first observed in the brain and 
subsequently spreads into the spinal cord (30). Viral titer reaches its peak at 
approximately day 5 post-infection.  Infectious viral particles are cleared within 
the first 7 to 10 days after infection, although viral RNA persists in the white 
matter of the spinal cord for several months (20, 29). Viral RNA persistence has 
been demonstrated in spinal cords of mice infected with demyelinating strains of 
MHV, including MHV-A59 and JHM (17, 20, 29), and has been suggested to be a 
prerequisite for MHV-induced demyelination.  Indeed, MHV-2 and Penn97-1(a 
non demyelinating recombinant strain of MHV) (3), which do not persist, also do 
not cause demyelination (4). Interestingly, the viral RNA of SMHV2-RA59, a 
chimeric strain (non-demyelinating strain of MHV, expressing MHV-2 spike gene 
in the MHV-A59 background, previously called Penn 98-1/2) persists in the spinal 
cord during chronic infection, and yet is unable to induce demyelination (4), 
indicating that viral RNA persistence in the spinal cord per se is insufficient to 
induce chronic demyelination.  Genes for the spike protein, which are known to 
mediate viral entry, if exchanged between strains may alter the capacity of MHV 
to infect and replicate in particular CNS cell types (neurons, astrocytes, microglia 
and oligodendrocytes) during the acute stage of infection, and therefore influence 
the induction of chronic demyelination. 
 
Little is known about the involvement of CNS cell tropism in MHV-induced 
demyelination.  It is known, however,  that in the CNS, demyelinating MHVs 
infect a variety of neural cell types, including neurons, astrocytes, 
oligodendrocytes, microglia, and ependymal cells (15, 19, 21, 43). Recently by 
using JHM spike chimeric viruses, Phillips et al. (32) demonstrated that spike 
gene-mediated neurovirulence of MHV is associated with extensive viral spread 
in the brain in both neurons and astrocytes.  However, no studies have examined 
whether non-demyelinating MHV strains infect the same CNS cell types as 
demyelinating strains. 
 
We have examined CNS cell tropism of both demyelinating and non-
demyelinating MHV strains during the acute stage of infection, in order to 
determine how the infection of a particular cell type(s) influences the likelihood of 
development of chronic demyelination.  This entailed asking whether non-
demyelinating strains differ in their ability to infect gray and white matter cells in 
the spinal cord during acute infection. 
We have used recombinant MHVs: SJHM-RA59EGFP (highly neurovirulent and 
demyelinating), RA59EGFP (weakly neurovirulent but demyelinating)(38), and 
SMHV2-RA59EGFP (neurotropic but non-demyelinating)(33).  All three viruses 
express enhanced green fluorescent protein (EGFP) and are isogenic, except for 
the spike gene, and differ in their neurovirulence and demyelination properties. 
 
During acute infection these three isogenic recombinant MHVs differ in spread 
and also in their CNS cell tropism.  Most interestingly, viral antigen of the 
demyelinating strains is first detected in gray matter, with subsequent localization 
to white matter; while antigen of non-demyelinating strains is mainly restricted to 
gray matter with occasional distribution to white matter.  The distribution of viral 
antigen in white matter during the acute stage of infection may be one of the key 
factors in chronic viral persistence and induction of demyelination.   
 
 Materials and Methods 
Viruses and cells: EGFP expressing recombinant viruses SJHM-RA59EGFP and 
RA59EGFP are isogenic except that SJHM-RA59EGFP expresses the JHM spike gene 
and RA59EGFP carries the MHV-A59 spike gene (38).  These two EGFP expressing 
viruses were generated from our previous studies (38) where they were named 
SJHM-REGFP and SA59-REGFP for SJHM-RA59EGFP and RA59EGFP, respectively.  
Construction of SMHV2-RA59EGFP: To construct a non demyelinating EGFP 
tagged isogenic recombinant strain SMHV2-RA59EGFP, the MHV-2 ( a non 
demyelinating MHV strain)(3) spike gene was cleaved from pMH54-SMHV2EGFP 
with AvrII and SbfI restriction digestion and inserted into the pMH54EGFP in place 
of the A59 spike gene (4).  Targeted RNA recombination was carried out as 
described in our previous published work (38).  For each desired recombinant, at 
least two strains derived from independent recombination events were 
characterized.  EGFP expressing viruses with the MHV-2 spike gene were 
labeled as SMHV2-RA59EGFP.  We previously used this recombinant EGFP 
tagged strain of SMHV2-RA59 in our other studies (33).  
Inoculation of mice: Four-week-old, MHV-free C57Bl/6 (B6) male mice 
(National Cancer Institute, Frederick, MD) were used in all experiments.  Mice 
were anesthetized with isoflurane (IsoFlo; Abbott Laboratories, North Chicago, 
IL) prior to inoculation. For intracranial inoculations, 20 µl of diluted virus (in PBS 
containing 0.75% bovine serum albumin) were injected into the left cerebral 
hemisphere. Mock-infected controls were inoculated similarly but with an 
uninfected 17Cl-1 cell lysate at a comparable dilution.  All experimental 
procedures were approved by the Institutional Animal Care and Use Committee. 
Virulence and viral titers in mice:  Virulence was assayed by calculating the 
lethal dose (LD50).  Mice were inoculated intracranially with 10-fold serial dilutions 
of viruses (five mice per dilution).  Signs of disease or death were monitored on a 
daily basis up to 30 days post infection.  LD(50) values were calculated by the 
Reed-Muench method (34).  For measurement of viral titers in the liver and the 
brain, mice were sacrificed at 1, 3, 5, 7, 9 and 11 days post infection and 
perfused with 2 ml of sterile PBS.  Brains and livers were removed aseptically 
and separately placed directly into 5 ml of isotonic saline with 0.167% gelatin (gel 
saline).  All organs were weighed and stored frozen at -80 ºC.  Brains and livers 
were homogenized, and viral titers were determined by plaque assay on L2 cell 
monolayers (4).  
Histopathological analysis:  For analysis of organ pathology, mice were 
infected intracranially, sacrificed at various times (day 3, 5, 7 and 10 post 
infection), and perfused with 5 ml of saline followed by 10% phosphate-buffered 
formalin.  Brains and spinal cords were removed and tissues were embedded in 
paraffin and sectioned for staining.  Brain and spinal cord sections were stained 
with hematoxylin and eosin (H&E) and used for pathological evaluations by light 
microscopy.  For assessment of demyelination, mice were inoculated 
intracranially with 0.5 LD
 (50) dose (8 mice per virus strain) and sacrificed at day 
30 post infection. Spinal cord sections were stained with Luxol fast blue to detect 
plaques of demyelination.  We repeated the demyelination experiment five times 
with 8 mice in each group.  Demyelination was quantified by examining four 
quadrants from two different levels of spinal cord sections for each mouse; thus 
approximately eighty quadrants were examined for each virus.  All slides were 
coded and read in a  blinded fashion (4).   
 
Immunohistochemical analysis: Immunohistochemical analysis was performed 
by the avidin-biotin-immunoperoxidase technique (Vector Laboratories, 
Burlington, CA) using 3,3’ diaminobenzidine as substrate, and a 1:20 dilution of 
monoclonal antibody (MAb) directed against the nucleocapsid protein (N) of 
MHV-JHM (Mab clone 1-16-1, kindly provided by Dr. Julian Leibowitz).  Control 
slides from mock-infected mice were incubated in parallel.  All slides were read in 
a blinded manner.  
 
Immunofluorescence: Mice were inoculated intracranially and sacrificed (5 mice 
per group) at days 3, 5, 7 post-infection.  Infected mice were perfused 
transcardially with PBS followed by cold PBS containing 4% paraformaldehyde 
and finally with 10 ml of PBS containing 10% sucrose.  Brains were removed and 
placed at 4 °C for 4 h in 10% sucrose and followed by 30% sucrose overnight. 
Tissues were embedded in OCT medium (Tissue Tek, Hatfield, PA), sectioned 
sagitally with a microtome to 6 µm thickness and mounted on glass slides.  Some 
sections were stained with H&E while others were left unstained for EGFP 
detection and immunofluorescence.  To detect EGFP fluorescence without 
immunostaining, frozen brain sections were fixed in ice-cold 95% ethanol for 20 
min, incubated at room temperature in ice-cold PBS for 10 min, and then 
mounted in 4.8% MOWIOL in 50% glycerol.  Sections were visualized using an 
Olympus X-70 microscope system with a 10X long-working distance UPlanF1 
phase objective and a filter pack suitable for green fluorescence (U-
MWIBABP460-490 DM505 BA515-550).  We repeated the acute stage cell 
tropism experiment with 5 mice in each group at 0.5 LD50 dose and repeated the 
experiment 3 times.   We also infected groups of 5 at 500 PFUs and 1000 PFUs 
and obtained similar results in terms of cellular tropism. This experiment was 
repeated twice.    
 
Double label immunofluorescence:  Frozen tissue sections were washed with 
PBS at room temperature in a humidified chamber, incubated for 10 min at room 
temperature with 1 mg/ml NaBH4 in PBS to reduce auto fluorescence, washed, 
incubated for 1 h at room temperature with 1 M glycine in PBS to reduce 
nonspecific cross linking, then washed subsequently with PBS, PBS + 0.5% 
Triton X-100 (TX) and PBS + TX + 2% goat serum (GS).  The sections were 
incubated overnight at 4ºC with a primary antiserum diluted in PBS+TX+GS, 
washed and then incubated with a secondary antiserum diluted into PBS+GS for 
2 h at room temperature.  All incubations were carried out in a humidified 
chamber. Viral antigen was detected by EGFP  in FITC channel (38).  Neurons 
were identified with a 1:50 dilution of mouse monoclonal antibody AP14(10), 
which recognizes the MAP2b protein (5, 36) (gift from Dr. Virginia M.-Y. Lee, 
University of Pennsylvania, PA).  Astrocytes were identified with a 1:100 dilution 
of a rabbit anti-cow glial fibrillary acidic protein (GFAP) (Dako Corp. Carpinteria, 
CA).  Secondary antibodies were 1:100 dilution of Texas red conjugated goat anti 
mouse IgG or anti rabbit IgG (Jackson Immune Research, West Grove, PA).  
Control slides were incubated in parallel with pre-immune rabbit sera, and 
sections from mock-infected mice were incubated with secondary antibodies 
only.  Tissue sections were sequentially washed with PBS+TX and PBS, 
mounted and visualized by fluorescence microscopy with a 40XUPlanApo oil 
immersion objective, with the iris diaphragm partially closed to limit the 
contribution of out-of-plane fluorescence, and with filter packs suitable for green 
fluorescence (U-MWIBA BP460-490 DM505 BA515-550) and red fluorescence 
(U-MNG BP530-550 DM570 BA590-800+).  Images were acquired with a 
Hamamatsu Orca-1 CCD camera and Image pro image analysis software (Media 
Cybernetics, Silver Spring, MD).    
 
 
 
 
Results 
Comparative pathogenesis of demyelinating and non-demyelinating 
strains:   We have compared the pathogenesis of SJHM-RA59EGFP, RA59EGFP 
and SMHV2-RA59EGFP, which are isogenic except for the spike gene (Fig 1).  We 
used half of an LD (50) (0.5LD50) for these pathogenesis studies; this dose for 
SJHM-RA59EGFP = 5,000 PFUs, for RA59EGFP = 20,000 and SMHV2-
RA59EGFP=100 PFUs.  We infected 8 mice in each group and repeated the 
experiment 5 times altogether.  Out of a total of 40 mice infected for each group, 
26 mice survived in the SJHM-RA59EGFP infected group, 30 mice survived in the 
RA59EGFP infected group and 24 mice survived in the SMHV2-RA59EGFP infected 
group at day 30 post infection.  Brain and spinal cord sections from mice infected 
intracranially with SJHM-RA59EGFP, RA59EGFP and SMHV2-RA59EGFP were 
stained either with H&E or Luxol fast blue and analyzed by light microscopy.  No 
demyelination was observed in any of the SMHV2-RA59EGFP (60% survival rate) 
infected mice  (Fig. 2 Upper Panel), similar to its parental recombinant virus 
SMHV2-RA59 (previously called Penn 98-1/2)(4).  In contrast, demyelination was 
observed in 100% of the RA59EGFP mice and 60% of the SJHM-RA59EGFP mice 
(> 70 % survival rate) (Fig. 2, Upper Panel).  This confirms our previous findings 
that the spike gene determines the demyelination property of MHV.   
 
In order to ensure that the non-demyelinating property of SMHV2-RA59EGFP is 
not due to its inability to replicate in the host, we carried out intracranial 
inoculations at 0.5  
LD (50) dose of two independently isolated clones of SMHV2-RA59EGFP and 
measured virus replication in mouse brain and liver as a function of time post-
infection.  The kinetics of viral replication and the final titers of viruses were 
similar, albeit slightly lower (10-fold), for the EGFP-expressing viruses compared 
to wild type recombinant virus. The peak of replication was observed at day 5, 
similar to previous studies (4, 31)(data not shown). 
 
Histopathological studies during acute phase of the infection revealed that all 
three viruses produced meningoencephalitis.  Brain pathology consisted of 
encephalitis, characterized by parenchymal lymphocytic infiltrates and microglial 
nodules with focal neuronophagia (Fig 2, Middle Panel). The parenchymal 
inflammation was more severe in SJHM-RA59EGFP infected mice brains than in 
RA59EGFP and SMHV2-RA59EGFP, and brain sections from RA59EGFP showed 
comparatively more parenchymal inflammation compared to SMHV2-RA59EGFP.  
Associated lymphocytic meningitis was also present in all three strains (Fig 2, 
Lower Panel).  Pathogenic properties of these viruses are summarized in Table 
1.   
 
Liver pathology consisted of moderate to severe hepatitis following RA59EGFP 
and SMHV2-RA59EGFP infection, similar to the respective parental recombinant 
strains (28). The infection is characterized by multiple foci of necrosis throughout 
the liver (data not shown).  We did not observe any liver pathology in SJHM-
RA59EGFP virus infected mice. 
 
Individual strains exhibit different cellular tropism:  To compare the cellular 
tropism of demyelinating versus non-demyelinating MHV strains, we performed 
double label immunofluorescence on sagittal brain sections.  Mice were 
inoculated intracranially with 0.5 LD
 (50) dose of SJHM-RA59EGFP, RA59EGFP and 
SMHV2-RA59EGFP.  Infected animals were sacrificed at days 3 and 5 post-
infection and frozen sections were made.  EGFP fluorescence was used to 
detect viral antigen positive cells, and immunofluorescent staining was carried 
out using MAP2b as a neuron specific marker, and GFAP as an astrocyte 
specific marker.  Sections were systematically scanned in a blinded fashion.  
Representative pictures of dual color fluorescence of viral antigen plus MAP2b 
and viral antigen plus GFAP are shown in Fig. 3 and 4, respectively.  Visual 
microscopic observations show that SJHM-RA59EGFP infects neurons more than 
the other two strains.   On the contrary, in SJHM-RA9EGFP infected mice only a 
very small number of viral antigen positive cells were also positive for the 
astrocytic marker GFAP, whereas in RA59EGFP infected mice, EGFP positive cells 
partially overlapped with GFAP staining.  It appears there are other CNS cells 
which are infected by RA59EGFP that are not astrocytes.  More surprisingly, in 
SMHV2-RA59EGFP infected mice EGFP positive cells were in complete overlap 
with GFAP, demonstrating that most infected cells were astrocytes.  Thus, 
SJHM-RA59EGFP is predominantly neuron tropic but may be less able to infect 
astrocytes.  RA59EGFP is multitropic and infects neurons as well as astrocytes and 
also other cell types in the CNS; SMHV2-RA59EGFP infects astrocytes mainly, and 
neurons with markedly reduced efficiency.  To avoid a high percentage of 
mortality at high virus dose and simultaneously to produce an optimal level of 
viral replication that does not damage the tissue to a degree that makes 
microscopic observation unsuitable, we chose a 0.5 LD50 dose. However, to 
ensure that viral tropism of virus during the acute stage of infection does not 
depend on the dose, we also performed experiments which demonstrate that the 
cellular tropism of SMHV2-RA59EGFP at 500 PFUs and 1000 PFUs at day 5 was 
similar to that at 100 PFU.  We also carried out infections with 500 PFUs and 
1000 PFUs of SJHM-RA59EGFP and RA59EGFP and observed the same CNS cell 
tropism as at higher dose, only with fewer infected cells. 
 
Demyelinating and non-demyelinating strains differ in their viral antigen 
localization in gray and white matter of the spinal cord.  To examine whether 
demyelinating and non-demyelinating strains differ in viral antigen distribution in 
spinal cord gray and white matter, we collected spinal cord tissues from SJHM-
RA59EGFP, RA59EGFP and SMHV2-RA59EGFP infected mice at days 5 and 7 post-
infection. Cross sections from several regions of all spinal cords were stained 
with viral anti nucleocapsid antiserum. 10 mice were sacrificed per time point 
following infection by a particular viral strain.  At day 5 post-infection viral 
antigens were mainly observed in the gray matter of the spinal cord for all three 
strains, but in SJHM-RA59EGFP and RA59EGFP infected mice some viral antigen 
was also detected in the white matter (Fig. 5, Upper Panel).  At day 7, most of 
the viral antigen in SJHM-RA59EGFP and RA59EGFP was found in white matter, 
whereas SMHV2-RA59EGFP viral antigen remained mainly restricted to gray 
matter with occasional distribution to white matter (Fig. 5, Middle Panel).  In 
SMHV2-RA59EGFP infected mice, viral antigen was occasionally observed in the 
white matter (3 of 60 spinal cord sections), and in some spinal cord sections of 
SMHV2-RA59EGFP viral antigen was detected at the gray- white matter junction 
as shown in Fig 5, Lower Panel. We repeated the experiment three times with 10 
mice in each group and we observed similar viral antigen distribution all three 
experiments.  
Discussion 
The current studies highlight the important role of neural cell tropism of viral 
antigen in MHV-induced demyelination in the CNS.  Localization studies showed 
that MHV strains that differ in their neurovirulence and ability to demyelinate also 
differ in their ability to infect particular CNS cell types.  SJHM-RA59EGFP infects 
neurons with greater efficiency, and infection may spread more rapidly than 
RA59EGFP, while SMHV2-RA59EGFP infects neurons with limited efficiency.  This is 
consistent with previous findings (32) that the degree of neurovirulence is not 
only dependent on neuronal tropism but also on the number of infected neurons 
and spread of the infection through neurites.  Evidence from closely related 
strains of neurotropic viruses including HIV, TMEV and reovirus supports the 
hypothesis that CNS cell tropism and spread in CNS cells play a major role in the 
distribution and type of CNS lesions (18, 41, 45). Studies with LCMV and HIV 
also suggest that virus strains that exhibit rapid spread are associated with 
increased immune-mediated pathology (27, 44).  Recently, it has been 
demonstrated that MHV spread to the spinal cord white matter occurs very 
rapidly and protection from demyelination can be achieved by inhibiting this viral 
spread during the acute phase of infection by recruiting high numbers of MHV 
specific CD8+T cells (23).   
Our study highlights the diverse modes of infection that may lead to 
demyelination. In our study the non-demyelinating strain is less able to infect 
neurons and spread through neurons; on the other hand, demyelinating strains 
are highly neuron tropic and spread rapidly through neurites. In contrast, it has 
been observed that a temperature-sensitive demyelinating mutant of JHM infects 
mainly non-neuronal cells, having a strong tropism specifically for astrocytes, and 
causes white matter lesions (11, 16). Similarly, it has been demonstrated that a 
monoclonal antibody selected JHM variant, a spike protein mutant, infects the 
glial cells predominantly in the CNS, causing subacute demyelination (8, 9). 
Interestingly, the neurotropic and non-demyelinating MHV3 strain, which has an 
in vitro tropism for neurons, ependymal cells, and meningial cells but not for 
astrocytes and oligodendrocytes, can induce an initial ependymitis, meningitis, 
and encephalitis in the absence of white matter lesions (40).  Our in vivo data 
demonstrate that the highly neurovirulent strain SJHM-RA59EGFP has very little 
tropism for astrocytes.  RA59EGFP and SMHV2-RA59EGFP infect astrocytes with 
similar efficiency.  As demyelinating and non-demyelinating strains produce 
similar infections in astrocytes, it appears that astrocytic infection during the 
acute stage alone may not determine the onset of demyelination.  Our 
observations suggest that astrocyte tropism may be a relevant factor in persistent 
infection but direct astrocytic infection alone may not be sufficient to induce 
demyelination. 
 
The development of chronic demyelination involves replication and spread of 
viral antigen in the spinal cord during the acute stage of infection and the 
persistence of viral RNA in white matter. This is substantiated by our 
observations on viral spread of non-demyelinating MHV in the spinal cord, where 
viral antigen during the acute phase of infection is mainly restricted to gray 
matter. In contrast, viral antigen from demyelinating strains spreads from gray to 
white matter during the acute stage of infection. Specifically, after intracranial 
infection and replication, viral antigens from the demyelinating strains SJHM-
RA59EGFP and RA59EGFP  are mostly seen in spinal cord gray matter at day 5 post 
infection and then in the white matter at day 7 post infection.  Our results 
establish that demyelinating and non-demyelinating strains differ in their viral 
antigen distribution in gray matter and white matter during acute infection. Viral 
persistence observed previously  in SMHV2-RA59  infected mouse spinal cord 
during the chronic phase of infection may be due to the presence of viral RNA in 
gray matter (4).  Viral RNA for demyelinating strains is known to persist mainly in 
the white matter (29). Due to lack of viral RNA persistence in the white matter, 
essential for the induction of demyelination during chronic infection, SMHV2-
RA59 is unable to induce demyelination.  It is possible that cell-specific viral RNA 
persistence is necessary for demyelination.  These combined observations 
reinforce the importance of glial cell infection in the onset of demyelination.  
 
It can also be argued that the spread of viral antigen from neuron to neuron and 
from neuron to glial cells plays a critical role in the induction of chronic stage 
demyelination.  Although there are no experimental data to demonstrate this, it 
can be suggested, based on our current neural cell tropism studies, that 
neuroinvasion by MHV may require entry into the nerve endings, transport to the 
cell body, replication in the cell body, axonal transport to the synapse and 
transneuronal viral spread. Similar mechanisms of axonal transport of virus 
particles have been observed for the alpha herpesviruses, Herpes simplex virus 
and pseudorabies virus (6, 7). Furthermore,  Theiler’s murine encephalitis virus 
(TMEV), a non-enveloped virus that, like MHV,  causes chronic demyelination in 
mice, is able to traffic from the axon into the surrounding myelin in the absence of 
cell lysis (37).  Thus, by a mechanism involving transneuronal spread, MHV may 
gain access to synaptically linked neuronal circuits and glial cells.  It is not clear 
however, which type(s) of glial cells must be infected in order to promote the 
development of MHV-induced chronic demyelinating disease.  
 
Our studies focused mainly on neurons and astrocytes, as they represent the 
majority of infected cells during the acute stage of MHV infection, but we cannot 
disregard oligodendrocytes.  It has been previously demonstrated that MHV can 
infect oligodendrocytes (22), but the direct cytolytic effect of MHV on 
oligodendrocytes is unclear (13, 14). Direct viral infection of oligodendrocytes 
may contribute to MHV-induced demyelination, as observed in another human 
demyelinating disease, progressive multifocal leukoencephalopathy (PML), which 
is caused by JC virus infection of oligodendrocytes (24, 35). Experiments are 
underway to optimize techniques that will facilitate detection of oligodendrocytes 
in MHV infected tissues.  
 
In summary, combined assessment of brain and spinal cord infections allows us 
to infer an indirect role of neuronal cell tropism in demyelination. SJHM-RA59EGFP 
and RA59EGFP infection can both spread from gray matter to white matter and 
induce demyelination.  The inability of the non-demyelinating strain of MHV, 
SMHV2-RA59EGFP, to spread from gray matter to white matter cells in the spinal 
cord may be due to its inefficient spread through neurites.  Acute stage 
inflammation and chronic stage demyelination may be two independent 
phenomena; however, acute stage neuronal infection and the lack of viral spread 
from neuronal to glial cells are likely key elements in the induction of 
demyelination.  
 
Acknowledgements  
This work was supported by advanced Postdoctoral Fellowship FG 1431-A-1 and 
RG3774A2-1 to JDS from the National Multiple Sclerosis Society, NIH grants 
GM061012 to MK; NIH grant AI60021 and NMSS grant RG 3843A6/1 to SRW.  
KTI was partially supported by NIH training grant NS-07180.  We thank Ming 
Ming Chua and Elsa Aglow for technical assistance and Susan T. Hingley for 
critically reading the manuscript.  
Fig. 1. EGFP tagged isogenic recombinant viruses differ in the spike gene.  
A schematic diagram of the MHV genome expressing EGFP replacing of gene 4a 
and part of gene 4b.  SJHM-RA59EGFP expressing the JHM spike; RA59EGFP 
expressing A59 spike gene and SMHV2-RA59EGFP in the background of A59 
gene.  All three recombinant viruses derived are isogenic, differing only in the 
spike gene.   
 
Fig. 2. CNS pathology of EGFP expressing MHVs.  Upper Panel. 
Demyelination: Luxol fast blue stained spinal cord sections of mice infected with 
SJHM-RA59EGFP, RA59EGFP or SMHV2-RA59EGFP, at day 30 post-infection. Thin 
arrows indicate a region of demyelination, and the arrowheads indicate normal 
myelinated area of white matter. Original magnifications 20X. 
 
Middle Panel. Encephalitis; microglial nodules: Hematoxylin- and Eosin-stained 
sections from the basal forebrain of mice infected with EGFP tagged MHVs at 
day 7 post-infection.  Arrows indicate the microglial nodules (microglia with 
elongated nuclei) and lymphocytes in the vicinity of neurons in mice infected with 
SJHM-RA59EGFP, RA59EGFP and SMHV2-RA59EGFP.  Original magnifications 
200X. 
 
Lower Panel. Meningitis.  Hematoxylin- and eosin-stained sections from the 
basal forebrain of mice infected with EGFP tagged MHVs at day 7 post-infection: 
SJHM-RA59EGFP, RA59EGFP and SMHV2-RA59EGFP.  In all cases, there is a brisk 
leptomeningeal lymphocytic inflammatory infiltrate. Original magnifications 200X. 
Fig. 3.  Identification of EGFP MHV-infected neurons in the brain at day 5 post-
infection.  Mice were infected intracranially with SJHM-RA59EGFP, RA59EGFP and 
SMHV2-RA59EGFP.  Infected mice were sacrificed at day 5 post-infection, and the 
brains were processed, sectioned and then labeled with anti MAP2b as primary- and 
with Texas red goat anti-mouse IgG as secondary- antibodies.  EGFP fluorescence 
(green) was used to detect viral antigen- positive cells in the basal forebrain.  Red 
fluorescence shows the corresponding labeling of MAP2b in neurons.  Merged 
images show colocalization of MAP2b and EGFP positive cells.  Arrows identify cells 
double positive for viral antigen and MAP2b.  Bar= 250 microns. 
 
Fig. 4. Colocalization of EGFP positive cells with astrocyte marker at day 5 
post-infection.  Mice were infected intracranially with SJHM-RA59EGFP, 
RA59EGFP and SMHV2-RA59EGFP.  Infected mice were sacrificed at day 5 post-
infection; brains were processed, sectioned and then immune labeled with anti 
GFAP (astrocytic marker) antiserum, then stained with Texas red goat anti-
mouse IgG as secondary antibodies.  EGFP fluorescence was used to detect 
viral antigen positive cells; red fluorescence was used to detect GFAP in 
astrocytes. Merged images show colocalization of GFAP and EGFP positive 
cells.  Arrows identify cells double positive for viral antigen and GFAP.  Bar= 250 
microns. 
 
Fig.5. Viral antigen expression in spinal cord sections of mice infected with 
EGFP- expressing viruses.  Mice were inoculated intracranially with SJHM-
RA59EGFP, RA59EGFP and SMHV2-RA59EGFP.  Mice were sacrificed at days 5 and 
7 post-infection, spinal cord sections were stained with anti nucleocapsid 
antiserum.  Representative hemi-sections and complete sections of spinal cords 
are shown from the cervical region of the spinal cord of day 5 (Upper Panel) and 
day 7 (Middle Panel) infected mice. In SMHV2-RA59EGFP infected mice 
occasional viral antigen distribution in the white matter and gray-white matter 
junction is shown in Lower Panel. 
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